Evidence map›Paper›PMID 42602162›Full record

ArticleJournal of tissue engineering

FGF-2 signaling dominance in TGF-β1/FGF-2-primed nasoseptal chondrocytes for cartilage tissue engineering.

Zhiyao Ma, Kiarra Grimes, Aillette Mulet-Sierra, Melanie Kunze, Kezhou Wu, Adetola B Adesida

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of tissue engineering. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhiyao MaDepartment of Surgery, Division of Orthopaedic Surgery, University of Alberta, Edmonton, AB, Canada.
Kiarra GrimesDepartment of Biomedical Engineering, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0009-0004-5799-7494
Aillette Mulet-SierraDepartment of Surgery, Division of Orthopaedic Surgery, University of Alberta, Edmonton, AB, Canada.
Melanie KunzeDepartment of Surgery, Division of Orthopaedic Surgery, University of Alberta, Edmonton, AB, Canada.
Kezhou WuDepartment of Surgery, Division of Orthopaedic Surgery, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0003-4452-2153
Adetola B AdesidaDepartment of Surgery, Division of Orthopaedic Surgery, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0003-1798-6251

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nasoseptal chondrocytes (NCs) are a viable cell source for engineering autologous hyaline cartilage grafts for nasal reconstruction or repairing articular cartilage lesions. Fibroblast growth factor (FGF)-2 and transforming growth factor (TGF)-β1 are commonly used to optimize cell yield and chondrogenic capacity during

Indexed as

cartilage tissue engineeringfibroblast growth factor 2 (FGF-2)microtissuesnasal chondrocytesseptal cartilagetranscriptomicstransforming growth factor beta 1 (TGF-β1)

Identifiers

PMID42602162
PMCPMC13473784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.